\nOntrak, Inc. (NASDAQ: OTRK) <\/b>(\u201cOntrak\u201d or the \u201cCompany\u201d), a leading AI-powered and telehealth-enabled, virtualized healthcare company, today announced it ranked 279 on Deloitte\u2019s Technology Fast 500<\/a>\u2122, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America, now in its 26th<\/sup> year. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2016 to 2019. In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company\u2019s operating revenues.\n<\/p>\n
\nOntrak Chairman and CEO, Terren Peizer, credits the proven savings and associated ROI, industry-leading member satisfaction scores and national customer expansions with the company\u2019s 376% revenue growth. \u201cWe are honored to be recognized for our proprietary IP and the technological innovation that enables Ontrak to identify, engage, and create lasting behavior change in the lives of those with unaddressed behavioral health conditions and chronic disease. Ontrak is humbled to be in the company of Technology Fast 500 award winners like Zoom (ranked 131) and Slack (ranked 236), whose growth trajectories have been driven by game-changing technology products with exceptionally high customer satisfaction scores. We are also proud to be the highest ranked healthcare IT company in the Technology Fast 500, amongst companies of similar size,\u201d said Mr. Peizer.\n<\/p>\n
\n\u201cFor more than 25 years, we\u2019ve been honoring companies that define the cutting edge and this year\u2019s Technology Fast 500 list is proof positive that technology \u2014 from software and digital media platforms, to biotech \u2014 truly does permeate so many facets of our lives,\u201d said Paul Silverglate<\/a>, vice chairman, Deloitte LLP and U.S. technology sector leader. \u201cWe congratulate this year\u2019s winners, especially during a time when innovation is needed more than ever to address the monumental challenges posed by the pandemic.\u201d\n<\/p>\n \n\u201cWe extend sincere congratulations to these well-deserved winners \u2014 who all embody a spirit of curiosity, and a never-ending commitment to making technology advancements possible,\u201d said Mohana Dissanayake<\/a>, partner, Deloitte & Touche LLP, and industry leader for technology, media and telecommunications, within Deloitte\u2019s audit and assurance practice.\n<\/p>\n About Deloitte\u2019s 2020 Technology Fast 500\u2122<\/b><\/p>\n \nNow in its 26th<\/sup> year, Deloitte\u2019s Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences and energy tech companies \u2014 both public and private \u2014 in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2016 to 2019.\n<\/p>\n \nIn order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company\u2019s operating revenues. Companies must have base-year operating revenues of at least $US50,000, and current-year operating revenues of at least $US5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.\n<\/p>\n About Ontrak, Inc.<\/b><\/p>\n \nOntrak, Inc. (f\/k\/a Catasys, Inc.) is a leading AI and telehealth enabled, virtualized healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The company\u2019s PRE\u2122 (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages people who are not getting the care they need. By combining predictive analytics with human engagement, Ontrak delivers improved member health and validated outcomes and savings to healthcare payers.\n<\/p>\n \nThe company\u2019s integrated, technology-enabled Ontrak\u2122 programs, a critical component of the PRE platform, are designed to provide healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs.\n<\/p>\n \nOntrak has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance.\n<\/p>\n \nOntrak integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaching and in-market Community Care Coordinators who address the social and environmental determinants of health, including loneliness. The company\u2019s programs improve member health and deliver validated cost savings to healthcare payers of more than 50 percent for enrolled members. Ontrak solutions are available to members of leading national and regional health plans in 30 states and in Washington, D.C.\n<\/p>\n \nLearn more at www.ontrak-inc.com<\/a><\/p>\n About Deloitte<\/b><\/p>\n \nDeloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (\u201cDTTL\u201d), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as \u201cDeloitte Global\u201d) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the \u201cDeloitte\u201d name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com\/about<\/a> to learn more about our global network of member firms.\n<\/p>\n Cautionary Note Regarding Forward-Looking Statements<\/b><\/p>\n Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control, which may cause actual results to differ materially from stated expectations. These risk factors include, among others, changes in regulations or issuance of new regulations or interpretations, limited operating history, our inability to execute our business plan, increase our revenue and achieve profitability, lower than anticipated eligible members under our contracts, our inability to recognize revenue, lack of outcomes and statistically significant formal research studies, difficulty enrolling new members and maintaining existing members in our programs, the risk that treatment programs might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the health care industry, the risks associated with the adequacy of our existing cash resources and our ability to continue as a going concern, our ability to raise additional capital when needed and our liquidity. You are urged to consider statements that include the words “may,” “will,” “would,” “could,” “should,” “believes,” “estimates,” “projects,” “potential,” “expects,” “plan,” “anticipates,” “intends,” “continues,” “forecast,” “designed,” “goal,” or the negative of those words or other comparable words to be uncertain and forward-looking. Forward looking statements may include statements regarding our proprietary IP and technological innovation allowing us to identify, engage, and create lasting behavior change in the lives of those with unaddressed behavioral health conditions and chronic disease. For a further list and description of the risks and uncertainties we face, please refer to our most recent Securities and Exchange Commission filings which are available on its website at http:\/\/www.sec.gov<\/a>. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.<\/i><\/p>\n View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201203005258\/en\/<\/a><\/span><\/p>\n Investors: KEYWORDS:<\/b> California United States North America<\/p>\n INDUSTRY KEYWORDS:<\/b> Data Management Practice Management Technology Health General Health Medical Devices Telecommunications Software Internet Fitness & Nutrition Mobile\/Wireless<\/p>\n<\/p>\n
\n<\/span><\/b>
Caroline Paul
\n
Gilmartin Group
\n
investors@ontrak-inc.com<\/a><\/p>\n
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20201203005258\/en\/832540\/3\/Picture1.jpg\")
<\/td>\n<\/tr>\n